AMERICAN STRATEGIC INVESTM-A (NYC) Fundamental Analysis & Valuation

NYSE:NYC • US6494393043

Current stock price

8.49 USD
+0.33 (+4.06%)
Last:

This NYC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NYC Profitability Analysis

1.1 Basic Checks

  • In the past year NYC has reported negative net income.
  • In the past year NYC has reported a negative cash flow from operations.
  • In the past 5 years NYC always reported negative net income.
  • NYC had a negative operating cash flow in each of the past 5 years.
NYC Yearly Net Income VS EBIT VS OCF VS FCFNYC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • NYC has a Return On Assets of -4.72%. This is in the lower half of the industry: NYC underperforms 62.90% of its industry peers.
  • Looking at the Return On Equity, with a value of -29.63%, NYC is doing worse than 69.35% of the companies in the same industry.
Industry RankSector Rank
ROA -4.72%
ROE -29.63%
ROIC N/A
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
NYC Yearly ROA, ROE, ROICNYC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • NYC has a Gross Margin (24.71%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of NYC has declined.
  • NYC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
NYC Yearly Profit, Operating, Gross MarginsNYC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NYC Health Analysis

2.1 Basic Checks

  • NYC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NYC has more shares outstanding
  • Compared to 5 years ago, NYC has more shares outstanding
  • The debt/assets ratio for NYC is higher compared to a year ago.
NYC Yearly Shares OutstandingNYC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
NYC Yearly Total Debt VS Total AssetsNYC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -2.00, we must say that NYC is in the distress zone and has some risk of bankruptcy.
  • NYC has a worse Altman-Z score (-2.00) than 82.26% of its industry peers.
  • A Debt/Equity ratio of 4.88 is on the high side and indicates that NYC has dependencies on debt financing.
  • NYC has a worse Debt to Equity ratio (4.88) than 82.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.88
Debt/FCF N/A
Altman-Z -2
ROIC/WACCN/A
WACC4.6%
NYC Yearly LT Debt VS Equity VS FCFNYC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 0.91 indicates that NYC may have some problems paying its short term obligations.
  • NYC has a worse Current ratio (0.91) than 77.42% of its industry peers.
  • NYC has a Quick Ratio of 0.91. This is a bad value and indicates that NYC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NYC's Quick ratio of 0.91 is on the low side compared to the rest of the industry. NYC is outperformed by 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
NYC Yearly Current Assets VS Current LiabilitesNYC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NYC Growth Analysis

3.1 Past

  • NYC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.73%, which is quite impressive.
  • The Revenue for NYC has decreased by -16.71% in the past year. This is quite bad
  • The Revenue has been decreasing by -2.68% on average over the past years.
EPS 1Y (TTM)89.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.28%
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-4.29%
Revenue growth 5Y-2.68%
Sales Q2Q%-20.58%

3.2 Future

  • NYC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.45% yearly.
  • NYC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.40% yearly.
EPS Next Y2.11%
EPS Next 2Y0.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.18%
Revenue Next 2Y2.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NYC Yearly Revenue VS EstimatesNYC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
NYC Yearly EPS VS EstimatesNYC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2023 2024 2025 2026 0 5 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

0

4. NYC Valuation Analysis

4.1 Price/Earnings Ratio

  • NYC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NYC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NYC Price Earnings VS Forward Price EarningsNYC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 138.22
NYC Per share dataNYC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.45%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NYC Dividend Analysis

5.1 Amount

  • No dividends for NYC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NYC Fundamentals: All Metrics, Ratios and Statistics

AMERICAN STRATEGIC INVESTM-A

NYSE:NYC (3/30/2026, 11:55:40 AM)

8.49

+0.33 (+4.06%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-26
Earnings (Next)05-07
Inst Owners2.02%
Inst Owner Change-10.28%
Ins Owners5.41%
Ins Owner Change0%
Market Cap22.67M
Revenue(TTM)51.69M
Net Income(TTM)-21.15M
Analysts45
Price TargetN/A
Short Float %0.06%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.44
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA 138.22
EPS(TTM)-25.61
EYN/A
EPS(NY)-12.33
Fwd EYN/A
FCF(TTM)-4.93
FCFYN/A
OCF(TTM)-4.52
OCFYN/A
SpS19.36
BVpS26.73
TBVpS26.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.72%
ROE -29.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.71%
FCFM N/A
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 4.88
Debt/FCF N/A
Debt/EBITDA 131.27
Cap/Depr 7.89%
Cap/Sales 2.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z -2
F-Score4
WACC4.6%
ROIC/WACCN/A
Cap/Depr(3y)13.9%
Cap/Depr(5y)12.89%
Cap/Sales(3y)5.75%
Cap/Sales(5y)5.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.28%
EPS Next Y2.11%
EPS Next 2Y0.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-4.29%
Revenue growth 5Y-2.68%
Sales Q2Q%-20.58%
Revenue Next Year3.18%
Revenue Next 2Y2.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.48%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICAN STRATEGIC INVESTM-A / NYC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AMERICAN STRATEGIC INVESTM-A (NYC) stock?

ChartMill assigns a fundamental rating of 0 / 10 to NYC.


What is the valuation status of AMERICAN STRATEGIC INVESTM-A (NYC) stock?

ChartMill assigns a valuation rating of 0 / 10 to AMERICAN STRATEGIC INVESTM-A (NYC). This can be considered as Overvalued.


Can you provide the profitability details for AMERICAN STRATEGIC INVESTM-A?

AMERICAN STRATEGIC INVESTM-A (NYC) has a profitability rating of 0 / 10.


Can you provide the financial health for NYC stock?

The financial health rating of AMERICAN STRATEGIC INVESTM-A (NYC) is 0 / 10.


What is the earnings growth outlook for AMERICAN STRATEGIC INVESTM-A?

The Earnings per Share (EPS) of AMERICAN STRATEGIC INVESTM-A (NYC) is expected to grow by 2.11% in the next year.